NYSE · Medical - Devices

AVNS (AVNS) Stock

$24.99 +0.04% NYSE: AVNS Healthcare

Valuation

MetricValue
Price$24.99
Market Cap$1.17B
P/E Ratio19.96
P/B Ratio1.49
P/S Ratio1.63
EPS (TTM)$0.00
52-Week High$25.49
52-Week Low$9.30
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-9.18%
ROA0.95%
ROCE-7.97%
Gross Margin48.55%
Operating Margin-7.92%
Net Margin-9.69%
Debt/Equity0.18
Current Ratio2.15

Annual Financials (USD)

Metric20212022202320242025
Revenue$745.0M$684.0M$673.0M$688.0M$701.0M
Operating Profit$87.0M$42.0M$65.0M$40.0M$-62.0M
Net Profit$6.0M$51.0M$-62.0M$-392.0M$-68.0M
EPS$0.13$1.07$-1.33$-8.53$-1.46
Op Margin11.7%6.1%9.7%5.8%-8.8%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$1.6B$1.8B$1.7B$1.2B$1.1B
Total Liabilities$333.0M$496.0M$456.0M$326.0M$296.0M
Cash$119.0M$128.0M$88.0M$108.0M$90.0M
Borrowings$188.0M$277.0M$209.0M$170.0M$129.0M

Latest News

AVNS: What does Argus have to say about AVNS? Argus Research · Jul 15, 2026 Avanos, American Industrial Get Regulatory Approval for Merger MT Newswires · Jul 2, 2026 Avanos Medical, Inc. and American Industrial Partners Receive Required Regulatory Approvals for Pending Merger PR Newswire · Jul 2, 2026 Tactile Systems Technology (TCMD) Moves 8.1% Higher: Will This Strength Last? Zacks · Jun 29, 2026 Reasons to Retain Avanos Medical Stock in Your Portfolio for Now Zacks · Jun 24, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$87.0M$91.0M$32.0M$101.0M$75.0M
Investing Cash Flow$-42.0M$-155.0M$4.0M$-45.0M$-92.0M
Financing Cash Flow$-5.0M$-47.0M$-29.0M$-15.0M$-3.0M
Net Cash Flow$7.0M$9.0M$-40.0M$20.0M$-18.0M
Free Cash Flow$66.0M$72.0M$15.0M$83.0M$43.0M

Valuation & Return Ratios

MetricValue
PEG Ratio24.14
EV / EBITDA22.21
FCF Yield0.64%
Quick Ratio1.40
Interest Coverage-15.50
Return 1Y106.28%
Return 3Y-2.19%
Return 5Y-27.63%

Ownership

Insiders Held3.28%
Institutions Held92.74%
Institutions Float Held95.89%
Institutional HolderSharesReport Date
Blackrock Inc.6,843,7332026-03-31
T. Rowe Price Investment Management, Inc.5,330,7762026-03-31
Brown Advisory Inc.2,231,1982026-03-31
Dimensional Fund Advisors LP2,052,3562026-03-31
Armistice Capital, LLC2,000,0002026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AORTArtivion, Inc. $23.30 -2.80% -374.33 $1.14B 0.00%
AXGNAxogen, Inc. $38.06 +3.76% -55.71 $2.23B 0.00%
CVSACovista Inc. $131.82 +0.15% 16.62 $4.46B 0.00%
ITGRInteger Holdings Corporation $126.54 -0.02% 34.27 $4.30B 0.00%
LIVNLivaNova PLC $80.90 -0.46% 22.17 $4.44B 0.00%

About AVNS

AVNS is led by CEO David C. Pacitti, employs 2,227 people, headquartered in US, publicly traded since 2014.

AVNS stock trades at $24.99 with a market capitalization of $1.17B. The stock is valued at a price-to-earnings (P/E) ratio of 19.96, price-to-book of 1.49, price-to-sales of 1.63. Over the past 52 weeks the stock has ranged between $9.30 and $25.49, and currently trades 2.0% below its 52-week high.

On profitability, AVNS generates a return on equity (ROE) of -9.18% (negative, reflecting a net loss), return on capital employed of -7.97%, an operating margin of -7.92%, a net profit margin of -9.69%.

AVNS by the numbers, 2016–2025

Between 2016 and 2025 AVNS reported revenue of $566.0M rising to $701.0M, a change of +23.9% across 10 years. Compounded, revenue has grown -0.4% a year over five years, 0.8% over three, 1.9% over the last twelve months. Net profit fell to $-68.0M.

Operating margin went from -12.3% in 2016 to -8.8% in 2025, a gain of 3.5 percentage points. The most recent net margin is -9.69%. On a trailing twelve-month basis to Mar '26, revenue is $716.0M and net profit $-69.0M.

Borrowings fell from $579.0M to $129.0M, cash from operations was $75.0M in the latest year, positive in 7 of the last 10.

Return on equity has averaged -11.3% over five years, and was -8.7% in the most recent year.

The share price itself has compounded at -9.1% a year over five years, -0.9% over three, 106.2% over the last year. Past price movement is history, not a forecast.

Figures are as reported and in the company's own reporting currency. They describe what has already happened and carry no implication about what follows.

AVNS (AVNS) — frequently asked questions

What is AVNS (AVNS) stock price today?

AVNS (AVNS) is currently trading at $24.99, up 0.04% today.

What is AVNS P/E ratio?

AVNS's P/E ratio is 19.96. This is between 15x and 30x, around the typical market average of roughly 18-22x.

What is AVNS return on equity (ROE)?

AVNS's return on equity (ROE) is -9.18%. ROE measures net income relative to shareholders' equity. A negative ROE means the company reported a net loss over the period.

What is AVNS's market cap?

AVNS has a market capitalization of $1.17B.

Does AVNS pay a dividend?

AVNS is not currently showing a dividend yield in our data, which means no recent cash dividend was recorded for it.

How much debt does AVNS carry?

AVNS has a debt-to-equity ratio of 0.18. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.

What is AVNS's profit margin?

AVNS reports a net profit margin of -9.69% — the share of revenue left after every cost, including tax and interest.

What sector is AVNS in?

AVNS is classified under Healthcare, in the Medical - Devices industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.

Which exchange is AVNS listed on?

AVNS trades on NYSE under the ticker AVNS.

What is AVNS's 52-week range?

Over the last year AVNS has traded between $9.30 and $25.49.

Related Healthcare Stocks

LLY Eli Lilly and Company $1273.46 -2.54% JNJ Johnson & Johnson $263.81 -1.42% ABBV AbbVie Inc. $285.64 +0.16% UNH UnitedHealth Group Incorporated Common Stock (DE) $418.09 -1.62% MRK Merck & Company, Inc. Common Stock (new) $145.27 -1.34% NVS Novartis AG $151.12 -3.30% AZN AstraZeneca PLC $171.49 -0.63% TMO Thermo Fisher Scientific Inc $673.82 -0.40% AMGN Amgen Inc. $439.26 -1.79% GILD Gilead Sciences, Inc. $156.04 -0.73% ABT Abbott Laboratories $103.70 +1.16% NVO Novo Nordisk A/S $39.05 -0.96%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens AVNS currently matches

On the figures above, AVNS passes the filters for 10 of our ready-made screens, among them Low Debt Stocks, Small Cap Stocks, Stocks With PE Under 20. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.

Low Debt StocksSmall Cap StocksStocks With PE Under 20Stocks Under $100Stocks Under $50NYSE Listed StocksStocks With PE Under 25Stocks With PE Under 30Debt to Equity Below 1 StocksHigh Current Ratio Stocks

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNYSE High ROE StocksAll stock screens
Run Stock Screener Investing Guides

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.